Stelara may be effective therapeutic for perianal Crohn’s

Stelara may be an effective therapeutic treatment in perianal refractory Crohn’s disease, according to results from the American Journal of Gastroenterology.“This large multicenter dedicated study adds substantial evidence to the growing literature on ustekinumab effectiveness in refractory CD,” Constance Chapuis-Biron, MD, from the department of gastroenterology at the University Hospital of Besançon, University Bourgogne Franche-Comté in Besançon, France, said.Chapuis-Biron and colleagues performed a multicenter retrospective study of 207 patients withRead More

Share on facebook
Share on twitter
Share on linkedin